Federal Register Notice: FDA is extending to 4/25/12 the comment period for the notice on its report of scientific and medical literature and information on the use of non-standardized allergenic extracts in the diagnosis and treatment of allergic disease that 9/26 Federal Register. To view this notice, click here.
